<ARTICLE> 5 <LEGEND> The schedule contains summary financial information extracted from Blonder Tongue Laboratories, Inc. and subsidiaries consolidated statement of earnings for the three-month period ended March 31, 2000 and balance sheet as at March 31, 2000 and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-END> MAR-31-2000 <CASH> 2,805 <SECURITIES> 0 <RECEIVABLES> 12,296 <ALLOWANCES> 762 <INVENTORY> 25,398 <CURRENT-ASSETS> 42,872 <PP&E> 13,315 <DEPRECIATION> 4,958 <TOTAL-ASSETS> 68,199 <CURRENT-LIABILITIES> 15,919 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 8 <OTHER-SE> 36,992 <TOTAL-LIABILITY-AND-EQUITY> 68,199 <SALES> 21,180 <TOTAL-REVENUES> 21,180 <CGS> 14,190 <TOTAL-COSTS> 14,190 <OTHER-EXPENSES> 3,902 <LOSS-PROVISION> 79 <INTEREST-EXPENSE> 583 <INCOME-PRETAX> 2,426 <INCOME-TAX> 845 <INCOME-CONTINUING> 1,581 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1,581 <EPS-BASIC> 0.21 <EPS-DILUTED> 0.21